GRAIL (NASDAQ:GRAL) Stock Quotes, Forecast and News Summary

Q: What sector and industry does GRAIL (GRAL) operate in?

GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

GRAIL Stock (NASDAQ: GRAL) stock price, news, charts, stock research, profile.

Open	$14.19
Close	$13.87
Volume / Avg.	710.11K / 1.48M
Day Range	$13.56 - $14.45
52 Wk Range	12.56 - 21.47
Market Cap	$430.65M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	43
Short Interest	-
Days to Cover	3.85

Recent News

European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine

Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million fine.

Vandana Singh

Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?

Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in September.

Piero Cingari

Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis

Illumina has acquired Fluent BioSciences, enhancing its single-cell analysis and multiomics capabilities. Fluent's innovative technology, including the PIPseq V system, offers cost-effective and scalable solutions, strengthening Illumina's market position and growth strategy.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About GRAIL Inc.

Sector

Health Care

Industry

Biotechnology

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GRAIL (GRAL) stock?

You can purchase shares of GRAIL (NASDAQ:GRAL) through any online brokerage.

View our list of the best stock brokerages

Who are GRAIL (GRAL) competitors?

Other companies in GRAIL’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).

What is the forecast, or price target, for GRAIL (GRAL) stock?

There is no analysis for GRAIL to provide a consensus price target.

What is the current price for GRAIL (GRAL)?

The stock price for GRAIL (NASDAQ: GRAL) is $13.87 last updated September 19, 2024 at 4:00 PM EDT.

Does GRAIL (GRAL) pay a dividend?

There are no upcoming dividends for GRAIL.

When is GRAIL (NASDAQ:GRAL) reporting earnings?

GRAIL’s Q3 earnings are confirmed for Friday, November 15, 2024.

Is GRAIL (GRAL) going to split?

There is no upcoming split for GRAIL.

What sector and industry does GRAIL (GRAL) operate in?

GRAIL is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now